BocaBio has been involved in solving the worlds pandemic concerns for three decades. We provided vital research support to the Dx and Pharma communities during the Zika outbreak of 2016. Little is known about the research that we continued to support on Zika even now in 2020. With the COVID-19 pandemic in full swing, BocaBio's entire team has been allocated to tackle this problem. We have focused our full capabilities as a hybrid CRO in the following ways to enhance all stages of diagnostic development as well as therapeutics.

  • Providing biological specimens critical for discovery R&D for Dx and therapeutic development, through our Biobanx division
  • Offering critically needed COVID-19 testing for PCR as well as serology through our CLIA/CAP accredited BocaBio Reference Lab division
  • Prospectively collecting both confirmed positive and negative COVID-19 patients for clinical trials support of Dx and Pharma development

As always, our entire BocaBio family stands vigilant, together, behind the scenes, doing our part to serve our community. 

Be safe, help others

Joseph Lawrence Mauro
Chief Vision Officer

COVID-19 Specialized Inventory

Boca Biolistics is announcing the launch of the BBL SARS-CoV-2 Validation Panel! The BBL SARS-CoV-2 panel will consist of non-contrived native human material, 30 positive and 30 negative NP/OP specimens characterized and designed for use on the Hologic Panther Fusion SARS-CoV-2 Test. Panel will be available mid-April. Due to limited stocks, contact your BBL sales rep for more information.

Accepting pre-orders, call us now for availability!


COVID-19 Research Support Capabilities

Individual commitment to a group effort--that is what makes a team work, a company work, a society work, a civilization work. 
Remnant Specimens for discovery R&D

NP/OP swabs, serum and plasma laboratory remnant specimens, received and processed under BBL's IRB approved de-linked proprietary process.

Currently available:

  • >500 NP swab specimens positive for COVID-19 by PCR
  • >500 NP swab specimens negative for COVID-19 by PCR
COVID-19 Panels

BBL announces the BBL SARS-CoV-2 validation panel for accelerated SARS-CoV-2 assay onboarding. Our propriety panel is comprised of native, non-contrived specimens NP/OP specimens and performed on the Hologic Panther Fusion platform.

We are also in development of additional panels for NP/OP specimens as well as serum and plasma for serological assay on-boarding. 

Custom panels are also available for manufacture upon request.


Boca Biolistics has launched a domestic and ex-US prospective clinical sample collection from subjects that have been diagnosed with COVID-19 and have an acute or convalescent infection.

The following sample matrices are collected per subject:

  • Plasma                       
  • Serum
  • Whole blood
  • NP swabs
  • Saliva

Data obtained from subjects includes the following:

  • Subject Demographics
  • Travel History
  • Symptoms and Date of Symptom Onset
  • Pre-Existing Medical Conditions
  • Concomitant Medications
  • COVID-19 Test Result
  • Other Respiratory Diagnostic Test Results (if available)

COVID-19 NAT is performed at Boca Biolistics Reference Lab.

COVID-19 Specimen Request Form
check mark black
Allow us to drive your COVID-19 research forward
Contact Us